Reshma Ramachandran, MD, MPP, MHS, not only believes in equitable access to healthcare and medical products but is a formidable force in advocating for it.
Reshma Ramachandran, MD, MPP, MHS
Assistant Professor of Medicine (General Medicine)Cards
About
Reshma Ramachandran is a primary care physician trained in family medicine and health services researcher. Her research focuses on developing evidence-driven strategies to ensure equitable access to meaningfully effective and safe health innovations in the United States and abroad.
Research
Publications
2026
Online Prescribing of GLP-1 Receptor Agonists.
Chetty AK, Chen AS, Ross JS, Ramachandran R. Online Prescribing of GLP-1 Receptor Agonists. JAMA 2026 PMID: 42406378, DOI: 10.1001/jama.2026.9131.Peer-Reviewed Original ResearchCommercial Price Variation for Common Dermatologic Procedures.
Deitelzweig C, Dhawan R, King K, Skydel J, Ramachandran R, Ross J, Yeung H, Wallach J. Commercial Price Variation for Common Dermatologic Procedures. JAMA Dermatology 2026 PMID: 42307923, PMCID: PMC13276662, DOI: 10.1001/jamadermatol.2026.1585.Peer-Reviewed Original ResearchStrategies for enhancing participation of underrepresented patient populations in cancer clinical trials: learning from “bright spots”
Miller J, Schwartz J, Ramachandran R, Ross J, Suttiratana S. Strategies for enhancing participation of underrepresented patient populations in cancer clinical trials: learning from “bright spots”. BMC Cancer 2026 PMID: 42288829, DOI: 10.1186/s12885-026-16181-1.Peer-Reviewed Original ResearchCancer clinical trialsClinical trialsPatient populationFDA approvalSpot trialsCancer clinical researchClinician engagementResultsThirteen participantsReferral trainingParticipation barriersPerformance-based incentivesOlder adultsCommunity partnershipsTrial teamLatinx patientsSite burdenNovel cancer therapeuticsEnrollment goalsEthnic subgroupsEligibility criteriaDisease burdenEducation programsReal-time dashboardTrial eligibilityLeadership commitmentInternet Searches for Leucovorin, Folate, and Acetaminophen After a White House Autism Announcement
Patel N, Ramachandran R, Ross J. Internet Searches for Leucovorin, Folate, and Acetaminophen After a White House Autism Announcement. JAMA Network Open 2026, 9: e2617910. PMID: 42275066, PMCID: PMC13261488, DOI: 10.1001/jamanetworkopen.2026.17910.Peer-Reviewed Original ResearchEconomic and Resource Use–Related Guidance in US Medical Societies’ Clinical Practice Guidelines
Habib A, Qureshi O, Ramachandran R, Ross J. Economic and Resource Use–Related Guidance in US Medical Societies’ Clinical Practice Guidelines. JAMA Network Open 2026, 9: e2620297. PMID: 42360742, PMCID: PMC13309863, DOI: 10.1001/jamanetworkopen.2026.20297.Peer-Reviewed Original ResearchConceptsClinical practice guidelinesValue-based careCross-sectional studyClinical practice guideline documentOdds ratioPractice guidelinesPrimary care societiesMedical societiesHealth economic evidenceMultilevel multivariate analysesCPG recommendationsMain OutcomesEconomic evidenceNarrative discussionCare SocietyMultisocietyCareMethodical manualsDiagnostic-relatedSummary StatementRecommendationsTreatment-relatedMultivariate analysisGuidelinesOddsHigh‐Risk Medication Prescribing Among Older Adults in the Emergency Department: A National Assessment
Follman S, Canavan M, Rothenberg C, Iscoe M, Venkatesh A, Ramachandran R, Gettel C. High‐Risk Medication Prescribing Among Older Adults in the Emergency Department: A National Assessment. Academic Emergency Medicine 2026, 33: e70321. PMID: 42136546, DOI: 10.1111/acem.70321.Peer-Reviewed Original ResearchConceptsDays of ED dischargeED dischargeOlder adultsMedication fillsMedication prescribingED visitsYounger cohorts of older adultsCohort of older adultsTransitions of careHigh-risk medicationsAssociated with higher oddsSystem-level factorsAdverse drug eventsCross-sectional studyYounger cohortsDays of dischargeMultivariate logistic regressionMedication safetyED encountersTargeted educationDrug eventsHigher oddsEmergency departmentSkeletal muscle relaxantsMedication classesSurrogate markers used as efficacy endpoints in NIH-sponsored clinical trials.
Mohammad A, Yoon S, Wallach J, Ramachandran R, Ross J. Surrogate markers used as efficacy endpoints in NIH-sponsored clinical trials. Clinical Trials 2026, 17407745261437294. PMID: 41995414, DOI: 10.1177/17407745261437294.Peer-Reviewed Original ResearchEvidence supporting European Medicines Agency drug approvals (2020-2023): A cross-sectional study of trial design and outcomes.
Siebert M, Caquelin L, Naudet F, Ross J, Ramachandran R. Evidence supporting European Medicines Agency drug approvals (2020-2023): A cross-sectional study of trial design and outcomes. Clinical Trials 2026, 17407745261437363. PMID: 41944409, DOI: 10.1177/17407745261437363.Peer-Reviewed Original ResearchEvidence standardsExpedited pathwaysEuropean Medicines AgencyDrug approvalEvidentiary strengthMedicines AgencyCross-sectional studyRandomized Controlled TrialsDrug regulationEuropean CommissionRegulatory judgmentsPrimary endpointRegulatory flexibilityCross-sectional analysisSurrogate endpointsEuropeanMedicinal productsPublic Assessment ReportsConditional approvalEuropean Medicines Agency approvalAdministration standardsClinical trial evidenceAgency approvalAssessment ReportJudgmentUS Food and Drug Administration Sentinel Initiative and Postmarket Drug Safety Surveillance
Taherifard E, Ross J, Ramachandran R, Wallach J. US Food and Drug Administration Sentinel Initiative and Postmarket Drug Safety Surveillance. JAMA Health Forum 2026, 7: e260754. PMID: 41996104, DOI: 10.1001/jamahealthforum.2026.0754.Peer-Reviewed Original ResearchConceptsFood and Drug Administration reportsElectronic health record dataFood and Drug AdministrationMedical product safety surveillanceSentinel InitiativeHealth record dataSystem informationClaims-based dataSafety surveillanceStandardized terminologyData linkageLack of standardized terminologyPrescription Drug User Fee ActAdministrative claimsClaims dataProduct reviewsRecord dataDrug studiesSafety concernsSystem assessmentUS Food and Drug AdministrationPublicly available informationInitiative websiteMedical productsARIA systemAdvertising Payments to News Websites That Publish Health Misinformation
Patel N, Ramachandran R, Ross J. Advertising Payments to News Websites That Publish Health Misinformation. JAMA Network Open 2026, 9: e265068. PMID: 41920545, PMCID: PMC13044671, DOI: 10.1001/jamanetworkopen.2026.5068.Peer-Reviewed Original Research
Clinical Care
Overview
Reshma Ramachandran, MD, is a physician specializing in internal medicine. She focuses on providing comprehensive care to adults, managing a diverse range of conditions, and promoting overall health and well-being through preventive measures and wellness strategies.
As an assistant professor of medicine at Yale School of Medicine, Dr. Ramachandran’s research is aimed at enhancing patient access to safe and effective health technologies. Her work concentrates on aligning healthcare incentives to prioritize equitable access, benefiting patients by improving healthcare policies related to medical product evaluation, approval, and coverage.
Dr. Ramachandran received her medical degree from the Alpert Medical School at Brown University and completed her family medicine residency at Kaiser Permanente Los Angeles Medical Center. She further honed her skills through a health services research and policy fellowship at the National Clinician Scholars Program at Yale.
News
News
- July 07, 2026
An Online Secret Shopping Study Reveals Easy Access to GLP-1 Prescriptions with Limited Clinician Oversight
- January 12, 2026Source: Regulatory Affairs Professionals Society
Experts raise concerns over lower evidentiary standard for FDA's leucovorin approval
- September 05, 2025Source: Medical Marketing & Media Online
Experts throw cold water on the idea that DTC platforms will meaningfully lower drug prices
- July 08, 2025Source: The New York Times Magazine
Inside the Collapse of the F.D.A.
Get In Touch
Contacts
Locations
E.S. Harkness Memorial Hall, Building A
Academic Office
367 Cedar Street, Rm 406A
New Haven, CT 06510
Patient Care Locations
Are You a Patient? View this doctor's clinical profile on the Yale Medicine website for information about the services we offer and making an appointment.